Diane C. Young

Diane Young currently serves as the Sr Vice President and Chief Medical Officer at Celldex Therapeutics and is the President of DCY Biopharma Consulting LLC. Additionally, Diane holds a board member position at the New Jersey Symphony Orchestra and previously served as a board member for The Valerie Fund. Prior experience includes roles as Chief Medical Officer at GTx, Inc., and Vice President at Novartis, where Diane led Clinical Development and Global Medical Affairs for Latin America. Diane's career in clinical development began at Johnson and Johnson, followed by positions at Sandoz and Hoffman-LaRoche. Diane completed medical education with an M.D. from Harvard Medical School and holds an A.B. in Biochemistry and Molecular Biology from Harvard University.